Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L De Sio

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1985
Effect of adjuvant tamoxifen and CMF on endocrine function of patients with operable breast cancerA R Bianco, S De Placido, C Pagliarulo, et al.
Anticancer Research|September 1, 1995
D-CECaT as preoperative chemotherapy for unresectable neuroblastoma in children over one year of ageA Donfrancesco, G Deb, C Dominici, et al.
American Journal of Clinical Oncology|August 1, 1992
Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastomaA Donfrancesco, G Deb, C Dominici, et al.
Anticancer Research|November 1, 1993
Peripheral blood stem cells in children with solid tumors. Part I. Feasibility and applicationG Deb, C Dominici, A Angioni, et al.
The British Journal of Ophthalmology|June 27, 2009
Metastatic retinoblastoma: single institution experience over two decadesR Cozza, M A De Ioris, I Ilari, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative GroupA Donfrancesco, B De Bernardi, M Carli, et al.
Tumori|February 28, 1986
Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifenG Delrio, S De Placido, C Pagliarulo, et al.
Progress in Clinical and Biological Research|January 1, 1991
High-dose carboplatin with etoposide (JET regimen) in children with advanced neuroblastomaM A Castello, A Donfrancesco, A Clerico, et al.
Bone Marrow Transplantation|January 26, 2010
Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's HospitalI Ilari, M A De Ioris, G M Milano, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|June 5, 2004
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of ageA Donfrancesco, A Jenkner, A Castellano, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1985
Effect of adjuvant tamoxifen and CMF on endocrine function of patients with operable breast cancerA R Bianco, S De Placido, C Pagliarulo, et al.
Anticancer Research|September 1, 1995
D-CECaT as preoperative chemotherapy for unresectable neuroblastoma in children over one year of ageA Donfrancesco, G Deb, C Dominici, et al.
American Journal of Clinical Oncology|August 1, 1992
Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastomaA Donfrancesco, G Deb, C Dominici, et al.
Anticancer Research|November 1, 1993
Peripheral blood stem cells in children with solid tumors. Part I. Feasibility and applicationG Deb, C Dominici, A Angioni, et al.
The British Journal of Ophthalmology|June 27, 2009
Metastatic retinoblastoma: single institution experience over two decadesR Cozza, M A De Ioris, I Ilari, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative GroupA Donfrancesco, B De Bernardi, M Carli, et al.
Tumori|February 28, 1986
Hypothalamic-pituitary-ovarian axis in women with operable breast cancer treated with adjuvant CMF and tamoxifenG Delrio, S De Placido, C Pagliarulo, et al.
Progress in Clinical and Biological Research|January 1, 1991
High-dose carboplatin with etoposide (JET regimen) in children with advanced neuroblastomaM A Castello, A Donfrancesco, A Clerico, et al.
Bone Marrow Transplantation|January 26, 2010
Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's HospitalI Ilari, M A De Ioris, G M Milano, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|June 5, 2004
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of ageA Donfrancesco, A Jenkner, A Castellano, et al.
Pageof 3